Aldeyra Therapeutics Inc’s recent filing unveils that its 10% Owner PERCEPTIVE ADVISORS LLC unloaded Company’s shares for reported $4.83 million on Apr 03 ’25. In the deal valued at $1.42 per share,3,400,000 shares were sold. As a result of this transaction, PERCEPTIVE ADVISORS LLC now holds 5,875,851 shares worth roughly $12.87 million.
Then, Machatha Stephen sold 16,041 shares, generating $75,975 in total proceeds. Upon selling the shares at $4.74, the Chief Development Officer now owns 236,771 shares.
Before that, Greenberg Bruce sold 10,834 shares. Aldeyra Therapeutics Inc shares valued at $51,313 were divested by the insider at a price of $4.74 per share. As a result of the transaction, Greenberg Bruce now holds 126,382 shares, worth roughly $0.28 million.
Oppenheimer upgraded its Aldeyra Therapeutics Inc [ALDX] rating to an Outperform from a a Perform in a research note published recently. H.C. Wainwright started covering the stock on February 08, 2021. It rated ALDX as “a Buy”.
Price Performance Review of ALDX
On Thursday, Aldeyra Therapeutics Inc [NASDAQ:ALDX] saw its stock jump 8.96% to $2.19. Over the last five days, the stock has gained 15.87%. Aldeyra Therapeutics Inc shares have fallen nearly -56.11% since the year began. Nevertheless, the stocks have fallen -43.41% over the past one year. While a 52-week high of $7.20 was reached on 03/12/25, a 52-week low of $1.14 was recorded on 04/03/25. SMA at 50 days reached $5.39, while 200 days put it at $5.08.
Levels Of Support And Resistance For ALDX Stock
The 24-hour chart illustrates a support level at 2.07, which if violated will result in even more drops to 1.95. On the upside, there is a resistance level at 2.27. A further resistance level may holdings at 2.34. The Relative Strength Index (RSI) on the 14-day chart is 29.45, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.58, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.59%. Stochastics %K at 17.98% indicates the stock is a buying.
How much short interest is there in Aldeyra Therapeutics Inc?
A steep rise in short interest was recorded in Aldeyra Therapeutics Inc stocks on 2025-03-31, dropping by 64841.0 shares to a total of 3.55 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 3.61 million shares. There was a decline of -1.83%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 16, 2020 when Berenberg began covering the stock and recommended ‘”a Buy”‘ rating along with a $32 price target.
